Physician profile
Allison C Moir
NPI 1033309851
$1,734.73
in general payments reported to CMS, 2019-2025
13 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.33 · 2021: $479 · 2022: $185 · 2023: $667 · 2024: $187 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $585 · Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $585.00 |
| Food and Beverage | $462.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionary Optics LLC | $985.00 | 2021-2023 | |
| Eyevance Pharmaceuticals LLC | $185.01 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $178.02 | 2023-2025 | Acuvue |
| Dompe US, INC. | $104.48 | 2019-2025 | Oxervate |
| Alcon Vision LLC | $89.02 | 2023-2025 | Hydrus Microstent, Acrysof Iq Vivity, Rocklatan |
| Coopervision INC. | $46.62 | 2021-2024 | Myday Contact Lens |
| Sun Pharmaceutical Industries INC. | $31.90 | 2025 | |
| Abbvie INC. | $28.12 | 2024 | |
| Aerie Pharmaceuticals, INC. | $22.07 | 2021 | |
| Thea Pharma INC. | $21.89 | 2024 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $17.04 | 2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $15.23 | 2024 | Miebo, Xiidra |
| Biotissue Holdings INC. | $10.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Moir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.